Coronavirus and our events

Image source:

The wellbeing of attendees at our meetings and events is of the utmost importance. We have been monitoring developments and advice from the UK Government and World Health Organization (WHO) about the outbreak of the novel coronavirus disease, COVID-19.

On Friday 13 March we announced that we cancelled our Cell Signalling 2020 meeting, due to be held in April. On 24 March, the same decision was taken for Current Trends in Drug Discovery, which was supposed to take place in June 2020. Speakers, abstract authors and delegates have all been informed by email. 

Our President's Lecture, due to be delivered by Dr Robert Langer, has been postponed and rescheduled for 18 February 2021.

Our training workshops in Pharmacogenomics in Drug Development, Pharmacokinetics and Pharmacodynamics and Clinical Toxicology, have all been postponed until 2021.
In the meantime, we ask that attendees take personal responsibility to keep up to date with and to follow Government advice.
If we cancel or postpone an event, we will offer a full refund of the delegate fee paid.

If you have any questions or concerns regarding our events and COVID-19, please contact


Article updated 23 April 2020

Published: 01 Apr 2020 in Society news